In South Africa, the current pregnant women living with hiv antiretroviral therapy coverage for pmtct is 98%, which reflects a decrease of 2% (-2.0%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in South Africa
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
Similar regions to South Africa
More indicators for South Africa
Male unintentional poisoning
1.8
+0.0
(2021)
Female wasting in children
3.6%
+0.8%
(2017)
Female prevalence of HIV
8.7%
-0.5%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar90
+intl dollar9
(2022)
Birth registration
88.6%
+3.6%
(2017)
Contraceptive modern method prevalence
54%
-5.9%
(2016)
South Africa PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 98% | -2% |
| 2021 | 100% | +1% |
| 2020 | 99% | 0% |
| 2019 | 99% | +1% |
| 2018 | 98% | +1% |
| 2017 | 97% | 0% |
| 2016 | 97% | 0% |
| 2015 | 97% | -3% |
| 2014 | 100% | 0% |
| 2013 | 100% | +4% |
| 2012 | 96% | +7% |
| 2011 | 89% | +4% |
| 2010 | 85% | +12% |
| 2009 | 73% | +15% |
| 2008 | 58% | +12% |
| 2007 | 46% | +12% |
| 2006 | 34% | +9% |
| 2005 | 25% | +10% |
| 2004 | 15% | +8% |
| 2003 | 7% | +3% |
| 2002 | 4% | +3% |
| 2001 | 1% | +1% |
| 2000 | 0% |